Method and pharmaceutical composition for treating leukoencephalitic demyelinization clinical patterns of autoimmune origin, particularly multiple sclerosis
US4882336A · kind A · utility
4Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 1988 |
| Grant date | Nov 21, 1989 |
| Priority date | — |
| Expiry date | Aug 17, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating demyelinization clinical patterns of autoimmune origin, particularly multiple sclerosis. The pharmaceutical composition makes use of ethyl (+)-apovincaminate as the active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.